12 Health Care Stocks Moving In Tuesday’s Intraday Session
Gainers Stoke Therapeutics (NASDAQ:STOK) stock moved upwards by 71.8% to $11.16 during Tuesday’s regular session. The company’s market…
Nuvation Bio Announces Departure Of Chief Financial Officer Jennifer Fox, Effective Date Of November 27, 2023
Nuvation Bio Inc. (NYSE:NUVB) (the "Company") announced today that Jennifer Fox will be stepping down from her role as Chief Financial Officer to pursue a new opportunity. Ms. Fox has advised the Company that she is
Nuvation Bio And 3 Other Stocks Under $4 Insiders Are Buying
The Dow Jones closed lower by more than 300 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Stocks That Hit 52-Week Lows On Tuesday
During Tuesday's session, 275 companies made new 52-week lows.
Stocks That Hit 52-Week Lows On Friday
Friday's session saw 169 companies set new 52-week lows.
Stocks That Hit 52-Week Lows On Friday
Friday's session saw 104 companies set new 52-week lows.
Analyst Expectations for Nuvation Bio’s Future
Over the past 3 months, 4 analysts have published their opinion on Nuvation Bio (NYSE:NUVB) stock. These analysts…
Where Nuvation Bio Stands With Analysts
Nuvation Bio (NYSE:NUVB) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat…
Wedbush Reiterates Outperform on Nuvation Bio, Maintains $5 Price Target
Wedbush analyst David Nierengarten reiterates Nuvation Bio (NYSE:NUVB) with a Outperform and maintains $5 price target.
RBC Capital Reiterates Outperform on Nuvation Bio, Maintains $6 Price Target
RBC Capital analyst Gregory Renza reiterates Nuvation Bio (NYSE:NUVB) with a Outperform and maintains $6 price target.